The price of Viking Therapeutics Inc (NASDAQ:VKTX) shares last traded on Wall Street fell -6.60% to $32.56.
VKTX stock price is now -33.03% away from the 50-day moving average and -45.01% away from the 200-day moving average. The market capitalization of the company currently stands at $3.63B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On November 22, 2024, B. Riley Securities recently initiated its ‘Buy’ rating on the stock quoting a target price of $109, while ‘H.C. Wainwright’ rates the stock as ‘Buy’
In other news, Lian Brian, President & CEO sold 194,490 shares of the company’s stock on Jan 06 ’25. The stock was sold for $8,313,601 at an average price of $42.75. Upon completion of the transaction, the President & CEO now directly owns 2,366,570 shares in the company, valued at $77.06 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 06 ’25, Chief Operating Officer Mancini Marianna sold 54,215 shares of the business’s stock. A total of $2,317,599 was realized by selling the stock at an average price of $42.75. This leaves the insider owning 374,134 shares of the company worth $12.18 million. A total of 3.11% of the company’s stock is owned by insiders.
During the past 12 months, Viking Therapeutics Inc has had a low of $20.28 and a high of $99.41. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 36.47, and a quick ratio of 36.47. The fifty day moving average price for VKTX is $49.4222 and a two-hundred day moving average price translates $59.448 for the stock.
The latest earnings results from Viking Therapeutics Inc (NASDAQ: VKTX) was released for 2024-09-30.
